Conavi Medical’s reverse merger with Titan Medical (TSX: TMD; OTC: TMDIF), which is expected to close in July 2024, and concurrent financing are anticipated to cultivate an investor network to help fund the expansion of...
BioRestorative Therapies (NASDAQ:BRTX) is a fully integrated regenerative medicine company with preclinical and Phase 2 clinical programs focused on conditioning the bodies’ regenerative potential to treat major...
iBio (NYSEA:IBO) is developing next-generation biopharmaceuticals leveraging computational biology and 3D-modeling of epitopes enabling the discovery of new antibody treatments for hard-to-target cancers and other...
TriSalus Life Sciences (NASDAQ:TLSI) is addressing the mechanical and biologic barriers within the tumor microenvironment (TME) that make it challenging to successfully treat liver and pancreatic tumors.